{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-067306","form_type":"8-K","ticker":"LRMR","cik":"0001374690","company_name":"Larimar Therapeutics, Inc.","filed_at":"2024-05-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.143243+00:00","generated_at":"2026-06-01T07:07:01.856929+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Larimar Therapeutics shareholders elect Class I directors, approve all proposals at 2024 annual meeting","bullets":["Jonathan Leff and Jeffrey Sherman re-elected as Class I directors with ~40.7M and ~51.1M votes for, respectively.","Advisory vote on executive compensation approved with ~48.8M for, ~2.4M against.","Ratification of PricewaterhouseCoopers LLP as auditor for FY2024 approved with ~59.6M for.","Amendment to certificate of incorporation regarding officer exculpation approved with ~50.9M for."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-067306","json":"https://secwatch.observer/filing/0000950170-24-067306.json","markdown":"https://secwatch.observer/filing/0000950170-24-067306.md","text":"https://secwatch.observer/filing/0000950170-24-067306.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1374690/000095017024067306/0000950170-24-067306-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1374690/000095017024067306/lrmr-20240529.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:07:01.856929+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}